Portal Hypertension Special Interest Group
Portal Hypertension Special Interest Group
The Portal Hypertension Special Interest Group (SIG) was established to facilitate collaborations in clinical and translational research, and to provide a platform to nurture discussion in best management of patients in this complex and rapidly evolving area. The SIG is linked to Cirrhosis and its Complications CRN topic area.
Portal Hypertension is a very active research area, with recent NIHR HTA funding of two randomised controlled trials which have the potential to become the largest ever clinical trials in cirrhosis. Translational research has been boosted by studies on non-invasive assessment of Portal Hypertension, and exciting new drugs. There is also much debate on the best management of patients with regard to medical and radiological therapies.
The SIG lead is Prof Alastair O'Brien of Royal Free Hospital, London.
If anyone wishes to join this group please contact the BASL Secretariat at sigs@basl.org.uk
Resources and meeting downloads
Updates
BSG Best Practice Guidance
BSG Best Practice Guidance: outpatient management of cirrhosis – part 1: compensated cirrhosis
BSG Best Practice Guidance: outpatient management of cirrhosis – part 2: decompensated cirrhosis
BSG Best Practice Guidance: outpatient management of cirrhosis – part 3: special circumstances
Guidelines and Guidance
Guidelines Transjugular Intrahepatic Portosystemic Stent-Shunt (TIPSS) in the management of portal hypertension (4/3/20) - https://gut.bmj.com/content/69/7/1173
Guidelines on the Management of Ascites in Cirrhosis - The British Society of Gastroenterology in collaboration with British Association for the Study of the Liver has prepared this document (11/11/20) - Download gutjnl-2020-321790.full_.pdf
Guidance document: risk assessment of patients with cirrhosis prior to elective non-hepatic surgery (13/3/23) - BASL / BSG endorsed and open access. All members of the BASL Portal Hypertension SIG Steering Committee contributed.
View and download the guidance on the BMJ website > Here .
